Search

Your search keyword '"Geraci, Giovanna"' showing total 19 results
Start Over Author "Geraci, Giovanna" Search Limiters Full Text
19 results on '"Geraci, Giovanna"'

1. Exploring the Perioperative Use of DOACs, off the Beaten Track

Author

Lucà, Fabiana, primary, Oliva, Fabrizio, additional, Giubilato, Simona, additional, Abrignani, Maurizio Giuseppe, additional, Rao, Carmelo Massimiliano, additional, Cornara, Stefano, additional, Caretta, Giorgio, additional, Di Fusco, Stefania Angela, additional, Ceravolo, Roberto, additional, Parrini, Iris, additional, Murrone, Adriano, additional, Geraci, Giovanna, additional, Riccio, Carmine, additional, Gelsomino, Sandro, additional, Colivicchi, Furio, additional, Grimaldi, Massimo, additional, and Gulizia, Michele Massimo, additional

Published
2024
Full Text
View/download PDF

2. Coagulation Tests and Reversal Agents in Patients Treated with Oral Anticoagulants: The Challenging Scenarios of Life-Threatening Bleeding and Unplanned Invasive Procedures

Author

Pozzi, Andrea, primary, Lucà, Fabiana, additional, Gelsomino, Sandro, additional, Abrignani, Maurizio Giuseppe, additional, Giubilato, Simona, additional, Di Fusco, Stefania Angela, additional, Rao, Carmelo Massimiliano, additional, Cornara, Stefano, additional, Caretta, Giorgio, additional, Ceravolo, Roberto, additional, Parrini, Iris, additional, Geraci, Giovanna, additional, Riccio, Carmine, additional, Grimaldi, Massimo, additional, Colivicchi, Furio, additional, Oliva, Fabrizio, additional, and Gulizia, Michele Massimo, additional

Published
2024
Full Text
View/download PDF

3. Takotsubo Syndrome and Gender Differences: Exploring Pathophysiological Mechanisms and Clinical Differences for a Personalized Approach in Patient Management.

Author

Giubilato, Simona, Francese, Giuseppina Maura, Manes, Maria Teresa, Rossini, Roberta, Della Bona, Roberta, Gatto, Laura, Di Monaco, Antonio, Zilio, Filippo, Gasparetto, Nicola, Sorini Dini, Carlotta, Borrello, Francesco, Mannarini, Antonia, Scardovi, Angela Beatrice, Pavan, Daniela, Amico, Francesco, Geraci, Giovanna, Riccio, Carmine, Colivicchi, Furio, Grimaldi, Massimo, and Gulizia, Michele Massimo

Subjects
TAKOTSUBO cardiomyopathy, SYMPATHETIC nervous system, ACUTE coronary syndrome, CORONARY artery disease, GENDER inequality
Abstract

Takotsubo syndrome (TTS), also known as the broken-heart syndrome, is a reversible condition typically observed in female patients presenting for acute coronary syndromes (ACS). Despite its increasing incidence, TTS often remains undiagnosed due to its overlap with ACS. The pathophysiology of TTS is complex and involves factors such as coronary vasospasm, microcirculatory dysfunction, increased catecholamine levels, and overactivity of the sympathetic nervous system. Diagnosing TTS requires a comprehensive approach, starting with clinical suspicion and progressing to both non-invasive and invasive multimodal tests guided by a specific diagnostic algorithm. Management of TTS should be personalized, considering potential complications, the presence or absence of coronary artery disease (CAD), diagnostic test results, and the patient's clinical course. The current data primarily derive from case series, retrospective analyses, prospective registries, and expert opinions. In recent years, there has been growing recognition of gender differences in the pathophysiology, presentation, and outcomes of TTS. This review provides an updated overview of gender disparities, highlighting the importance of tailored diagnostic and management strategies. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

4. Multidisciplinary Approach in Atrial Fibrillation: As Good as Gold.

Author

Lucà, Fabiana, Abrignani, Maurizio Giuseppe, Oliva, Fabrizio, Canale, Maria Laura, Parrini, Iris, Murrone, Adriano, Rao, Carmelo Massimiliano, Nesti, Martina, Cornara, Stefano, Di Matteo, Irene, Barisone, Michela, Giubilato, Simona, Ceravolo, Roberto, Pignalberi, Carlo, Geraci, Giovanna, Riccio, Carmine, Gelsomino, Sandro, Colivicchi, Furio, Grimaldi, Massimo, and Gulizia, Michele Massimo

Subjects
ATRIAL fibrillation, MEDICAL personnel, DISEASE progression, PATIENT care, CARDIOLOGISTS
Abstract

Atrial fibrillation (AF) represents the most common sustained arrhythmia necessitating dual focus: acute complication management and sustained longitudinal oversight to modulate disease progression and ensure comprehensive patient care over time. AF is a multifaceted disorder; due to such a great number of potential exacerbating conditions, a multidisciplinary team (MDT) should manage AF patients by cooperating with a cardiologist. Effective management of AF patients necessitates the implementation of a well-coordinated and tailored care pathway aimed at delivering optimized treatment through collaboration among various healthcare professionals. Management of AF should be carefully evaluated and mutually agreed upon in consultation with healthcare providers. It is crucial to recognize that treatment may evolve due to the emergence of new risk factors, symptoms, disease progression, and advancements in treatment modalities. In the context of multidisciplinary AF teams, a coordinated approach involves assembling a diverse team tailored to meet individual patients' unique needs based on local services' availability. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

5. Aspirin in Primary Prevention: Looking for Those Who Enjoy It.

Author

Della Bona, Roberta, Giubilato, Simona, Palmieri, Marco, Benenati, Stefano, Rossini, Roberta, Di Fusco, Stefania Angela, Novarese, Filippo, Mascia, Giuseppe, Gasparetto, Nicola, Di Monaco, Antonio, Gatto, Laura, Zilio, Filippo, Sorini Dini, Carlotta, Borrello, Francesco, Geraci, Giovanna, Riccio, Carmine, De Luca, Leonardo, Colivicchi, Furio, Grimaldi, Massimo, and Giulizia, Michele Massimo

Subjects
ANTILIPEMIC agents, ASPIRIN, CANCER prevention, CARDIOVASCULAR diseases risk factors, DISEASE risk factors
Abstract

Based on a wealth of evidence, aspirin is one of the cornerstones of secondary prevention of cardiovascular disease. However, despite several studies showing efficacy also in primary prevention, an unopposed excess risk of bleeding leading to a very thin safety margin is evident in subjects without a clear acute cardiovascular event. Overall, the variability in recommendations from different scientific societies for aspirin use in primary prevention is a classic example of failure of simple risk stratification models based on competing risks (atherothrombosis vs. bleeding), perceived to be opposed but intertwined at the pathophysiological level. Notably, cardiovascular risk is dynamic in nature and cannot be accurately captured by scores, which do not always consider risk enhancers. Furthermore, the widespread use of other potent medications in primary prevention, such as lipid-lowering and anti-hypertensive drugs, might be reducing the benefit of aspirin in recent trials. Some authors, drawing from specific pathophysiological data, have suggested that specific subgroups might benefit more from aspirin. This includes patients with diabetes and those with obesity; sex-based differences are considered as well. Moreover, molecular analysis of platelet reactivity has been proposed. A beneficial effect of aspirin has also been demonstrated for the prevention of cancer, especially colorectal. This review explores evidence and controversies concerning the use of aspirin in primary prevention, considering new perspectives in order to provide a comprehensive individualized approach. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

6. Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) scientific statement on the simplification of the drug regimen for secondary cardiovascular prevention

Author

De Luca, Leonardo, Di Fusco, Stefania Angela, Iannopollo, Gianmarco, Mistrulli, Raffaella, Rizzello, Vittoria, Aimo, Alberto, Navazio, Alessandro, Bilato, Claudio, Corda, Marco, Di Marco, Massimo, Geraci, Giovanna, Iacovoni, Attilio, Milli, Massimo, Pascale, Vittorio, Riccio, Carmine, Scicchitano, Pietro, Tizzani, Emanuele, Gabrielli, Domenico, Grimaldi, Massimo, Colivicchi, Furio, and Oliva, Fabrizio

Abstract

The issue of suboptimal drug regimen adherence in secondary cardiovascular prevention presents a significant barrier to improving patient outcomes. To address this, the utilization of drug combinations, specifically single pill combinations (SPCs) and polypills, was proposed as a strategy to simplify treatment regimens. This approach aims to enhance treatment accessibility, affordability, and adherence, thereby reducing healthcare costs and improving patient health. The document is an Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) scientific statement on simplifying drug regimens for secondary cardiovascular prevention. It discusses the underuse of treatments despite available, effective, and accessible options, highlighting a significant gap in secondary prevention across different socio-economic statuses and countries. The statement explores barriers to implementing evidence-based treatments, including patient, healthcare provider, and system-related challenges. The paper also reviews international guidelines, the role of SPCs and polypills in clinical practice, and their economic impact, advocating for their use in secondary prevention to improve patient outcomes and adherence.

Published
2024
Full Text
View/download PDF

7. Italian Association of Hospital Cardiologists Position Paper ‘Gender discrepancy: time to implement gender-based clinical management’

Author

Lucà, Fabiana, Pavan, Daniela, Gulizia, Michele Massimo, Manes, Maria Teresa, Abrignani, Maurizio Giuseppe, Benedetto, Francesco Antonio, Bisceglia, Irma, Brigido, Silvana, Caldarola, Pasquale, Calvanese, Raimondo, Canale, Maria Laura, Caretta, Giorgio, Ceravolo, Roberto, Chieffo, Alaide, Chimenti, Cristina, Cornara, Stefano, Cutolo, Ada, Di Fusco, Stefania Angela, Di Matteo, Irene, Di Nora, Concetta, Fattirolli, Francesco, Favilli, Silvia, Francese, Giuseppina Maura, Gelsomino, Sandro, Geraci, Giovanna, Giubilato, Simona, Ingianni, Nadia, Iorio, Annamaria, Lanni, Francesca, Montalto, Andrea, Nardi, Federico, Navazio, Alessandro, Nesti, Martina, Parrini, Iris, Pilleri, Annarita, Pozzi, Andrea, Rao, Carmelo Massimiliano, Riccio, Carmine, Rossini, Roberta, Scicchitano, Pietro, Valente, Serafina, Zuccalà, Giuseppe, Gabrielli, Domenico, Grimaldi, Massimo, Colivicchi, Furio, and Oliva, Fabrizio

Abstract

It has been well assessed that women have been widely under-represented in cardiovascular clinical trials. Moreover, a significant discrepancy in pharmacological and interventional strategies has been reported. Therefore, poor outcomes and more significant mortality have been shown in many diseases. Pharmacokinetic and pharmacodynamic differences in drug metabolism have also been described so that effectiveness could be different according to sex. However, awareness about the gender gap remains too scarce. Consequently, gender-specific guidelines are lacking, and the need for a sex-specific approach has become more evident in the last few years. This paper aims to evaluate different therapeutic approaches to managing the most common women’s diseases.

Published
2024
Full Text
View/download PDF

8. Italian Association of Hospital Cardiologists position paper—obesity in adults: a clinical primer

Author

Di Fusco, Stefania Angela, Mocini, Edoardo, Gori, Mauro, Iacoviello, Massimo, Bilato, Claudio, Corda, Marco, De Luca, Leonardo, Di Marco, Massimo, Geraci, Giovanna, Iacovoni, Attilio, Milli, Massimo, Navazio, Alessandro, Pascale, Vittorio, Riccio, Carmine, Scicchitano, Pietro, Tizzani, Emanuele, Gabrielli, Domenico, Grimaldi, Massimo, Colivicchi, Furio, and Oliva, Fabrizio

Abstract

Obesity is a chronic and relapsing disease characterized by the interaction between individual predispositions and an obesogenic environment. Recent advances in understanding the mechanisms of energetic homoeostasis paved the way to more effective therapeutic approaches compared with traditional treatments. Since obesity is a complex disease, it necessitates a multi-disciplinary approach whose implementation remains challenging. Nonetheless, emerging pharmacological interventions appear promising. Currently, therapeutic success is discreet in the short term but often fails to maintain long-term weight loss due to a high likelihood of weight regain. Cardiologists play a key role in managing patients with obesity, yet often lack familiarity with its comprehensive management. The aim of this document is to summarize knowledge to consolidate essential knowledge for clinicians to effectively treat patients living with obesity. The paper emphasizes the pivotal role of a strong patient–clinician relationship in navigating successful treatment. We analyse the criteria commonly used to diagnose obesity and point out the strengths and limitations of different criteria. Furthermore, we discuss the role of obesiologists and the contributions of cardiologists. In addition, we detail key components of effective therapeutic strategies, including educational aspects and pharmacological options.

Published
2024
Full Text
View/download PDF

9. ANMCO/SIMEU consensus document on the use of reversal agents for antithrombotic therapies in patients with ongoing bleeding or at high risk of haemorrhagic events

Author

De Luca, Leonardo, Pugliese, Francesco Rocco, Susi, Beniamino, Navazio, Alessandro, Corda, Marco, Fabbri, Andrea, Scicchitano, Pietro, Voza, Antonio, Vanni, Simone, Bilato, Claudio, Geraci, Giovanna, Gabrielli, Domenico, Grimaldi, Massimo, Colivicchi, Furio, De Iaco, Fabio, and Oliva, Fabrizio

Abstract

In recent decades, an incredible evolution in antithrombotic therapies used for treating patients with atherosclerosis, atrial fibrillation, and venous thromboembolism has been observed, leading to the availability of increasingly safe drugs. Nonetheless, bleeding complications remain a significant concern, with considerable health, social, and economic implications. To improve the acute management of patients experiencing or at risk for major bleeding events, specific reversal agents for antithrombotic drugs have been recently developed. While these agents demonstrate effectiveness in small-scale pharmacodynamic studies and clinical trials, it is imperative to balance the benefits of reversing antiplatelet or anticoagulant therapy against the risk of prothrombotic effects. These risks include the potential loss of antithrombotic protection and the prothrombotic tendencies associated with bleeding, major surgery, or trauma. This joint document of the Italian Association of Hospital Cardiologists (Associazione Nazionale Medici Cardiologi Ospedalieri) and the Italian Society of Emergency Medicine (Società Italiana di Medicina d’Emergenza-Urgenza) delineates the key features and efficacy of available reversal agents. It also provides practical flowcharts to guide their use in patients with active bleeding or those at elevated risk of major bleeding events.

Published
2024
Full Text
View/download PDF

10. Corrigendum: Cardio-oncology in the COVID Era (Co & Co): The never-ending story

Author

Bisceglia, Irma, primary, Canale, Maria Laura, additional, Gallucci, Giuseppina, additional, Turazza, Fabio Maria, additional, Lestuzzi, Chiara, additional, Parrini, Iris, additional, Russo, Giulia, additional, Maurea, Nicola, additional, Quagliariello, Vincenzo, additional, Oliva, Stefano, additional, Angela Di Fusco, Stefania, additional, Lucà, Fabiana, additional, Tarantini, Luigi, additional, Trambaiolo, Paolo, additional, Moreo, Antonella, additional, Geraci, Giovanna, additional, Gabrielli, Domenico, additional, Gulizia, Michele Massimo, additional, Oliva, Fabrizio, additional, and Colivicchi, Furio, additional

Published
2023
Full Text
View/download PDF

11. Corrigendum: Cardio-Oncology in the COVID Era (Co & Co): The Never Ending Story

Author

Bisceglia, Irma, primary, Canale, Maria Laura, additional, Gallucci, Giuseppina, additional, Turazza, Fabio Maria, additional, Lestuzzi, Chiara, additional, Parrini, Iris, additional, Russo, Giulia, additional, Maurea, Nicola, additional, Quagliariello, Vincenzo, additional, Oliva, Stefano, additional, Di Fusco, Stefania Angela, additional, Lucà, Fabiana, additional, Tarantini, Luigi, additional, Trambaiolo, Paolo, additional, Moreo, Antonella, additional, Geraci, Giovanna, additional, Gabrielli, Domenico, additional, Gulizia, Michele Massimo, additional, Oliva, Fabrizio, additional, and Colivicchi, Furio, additional

Published
2022
Full Text
View/download PDF

12. Cardio-Oncology in the COVID Era (Co & Co): The Never Ending Story

Author

Bisceglia, Irma, primary, Canale, Maria Laura, additional, Gallucci, Giuseppina, additional, Turazza, Fabio Maria, additional, Lestuzzi, Chiara, additional, Parrini, Iris, additional, Russo, Giulia, additional, Maurea, Nicola, additional, Quagliariello, Vincenzo, additional, Oliva, Stefano, additional, Di Fusco, Stefania Angela, additional, Lucà, Fabiana, additional, Tarantini, Luigi, additional, Trambaiolo, Paolo, additional, Moreo, Antonella, additional, Geraci, Giovanna, additional, Gabrielli, Domenico, additional, Gulizia, Michele Massimo, additional, Oliva, Fabrizio, additional, and Colivicchi, Furio, additional

Published
2022
Full Text
View/download PDF

14. Consensus Document of the Italian Association of Hospital Cardiologists (ANMCO), Italian Society of Pediatric Cardiology (SICP), and Italian Society of Gynaecologists and Obstetrics (SIGO): pregnancy and congenital heart diseases

Author

Bianca, Innocenzo, primary, Geraci, Giovanna, additional, Gulizia, Michele Massimo, additional, Egidy Assenza, Gabriele, additional, Barone, Chiara, additional, Campisi, Marcello, additional, Alaimo, Annalisa, additional, Adorisio, Rachele, additional, Comoglio, Francesca, additional, Favilli, Silvia, additional, Agnoletti, Gabriella, additional, Carmina, Maria Gabriella, additional, Chessa, Massimo, additional, Sarubbi, Berardo, additional, Mongiovì, Maurizio, additional, Russo, Maria Giovanna, additional, Bianca, Sebastiano, additional, Canzone, Giuseppe, additional, Bonvicini, Marco, additional, Viora, Elsa, additional, and Poli, Marco, additional

Published
2017
Full Text
View/download PDF

15. ANMCO Position Paper: direct oral anticoagulants for stroke prevention in atrial fibrillation: clinical scenarios and future perspectives

Author

Nardi, Federico, primary, Gulizia, Michele Massimo, additional, Colivicchi, Furio, additional, Abrignani, Maurizio Giuseppe, additional, Di Fusco, Stefania Angela, additional, Di Lenarda, Andrea, additional, Di Tano, Giuseppe, additional, Geraci, Giovanna, additional, Moschini, Luigi, additional, Riccio, Carmine, additional, Verdecchia, Paolo, additional, and Enea, Iolanda, additional

Published
2017
Full Text
View/download PDF

16. ANMCO Position Paper: hospital discharge planning: recommendations and standards

Author

Mennuni, Mauro, primary, Gulizia, Michele Massimo, additional, Alunni, Gianfranco, additional, Francesco Amico, Antonio, additional, Maria Bovenzi, Francesco, additional, Caporale, Roberto, additional, Colivicchi, Furio, additional, Di Lenarda, Andrea, additional, Di Tano, Giuseppe, additional, Egman, Sabrina, additional, Fattirolli, Francesco, additional, Gabrielli, Domenico, additional, Geraci, Giovanna, additional, Gregorio, Giovanni, additional, Francesco Mureddu, Gian, additional, Nardi, Federico, additional, Radini, Donatella, additional, Riccio, Carmine, additional, Rigo, Fausto, additional, Sicuro, Marco, additional, Urbinati, Stefano, additional, and Zuin, Guerrino, additional

Published
2017
Full Text
View/download PDF

17. Consensus Document of the Italian Association of Hospital Cardiologists (ANMCO), Italian Society of Cardiology (SIC), Italian Association of Interventional Cardiology (SICI-GISE) and Italian Society of Cardiac Surgery (SICCH): clinical approach to pharmacologic pre-treatment for patients undergoing myocardial revascularization procedures

Author

Caporale, Roberto, primary, Geraci, Giovanna, additional, Gulizia, Michele Massimo, additional, Borzi, Mauro, additional, Colivicchi, Furio, additional, Menozzi, A., additional, Musumeci, Giuseppe, additional, Scherillo, Marino, additional, Ledda, Antonietta, additional, Tarantini, Giuseppe, additional, Gerometta, Piersilvio, additional, Casolo, Giancarlo, additional, Formigli, Dario, additional, Romeo, Francesco, additional, and Di Bartolomeo, Roberto, additional

Published
2017
Full Text
View/download PDF

18. Consensus Document ANMCO/ANCE/ARCA/GICR-IACPR/GISE/SICOA: Long-term Antiplatelet Therapy in Patients with Coronary Artery Disease

Author

Gulizia, Michele Massimo, Colivicchi, Furio, Abrignani, Maurizio Giuseppe, Ambrosetti, Marco, Aspromonte, Nadia, Barile, Gabriella, Caporale, Roberto, Casolo, Giancarlo, Chiuini, Emilia, Di Lenarda, Andrea, Faggiano, Pompilio, Gabrielli, Domenico, Geraci, Giovanna, La Manna, Alessio Gaetano, Maggioni, Aldo Pietro, Marchese, Alfredo, Massari, Ferdinando Maria, Mureddu, Gian Francesco, Musumeci, Giuseppe, Nardi, Federico, Panno, Antonio Vittorio, Pedretti, Roberto Franco Enrico, Piredda, Massimo, Pusineri, Enrico, Riccio, Carmine, Rossini, Roberta, di Uccio, Fortunato Scotto, Urbinati, Stefano, Varbella, Ferdinando, Zito, Giovanni Battista, and De Luca, Leonardo

Abstract

Dual antiplatelet therapy (DAPT) with aspirin and a P2Y12receptor inhibitor is the cornerstone of pharmacologic management of patients with acute coronary syndrome (ACS) and/or those receiving coronary stents. Long-term (>1 year) DAPT may further reduce the risk of stent thrombosis after a percutaneous coronary intervention (PCI) and may decrease the occurrence of non-stent-related ischaemic events in patients with ACS. Nevertheless, compared with aspirin alone, extended use of aspirin plus a P2Y12receptor inhibitor may increase the risk of bleeding events that have been strongly linked to adverse outcomes including recurrent ischaemia, repeat hospitalisation and death. In the past years, multiple randomised trials have been published comparing the duration of DAPT after PCI and in ACS patients, investigating either a shorter or prolonged DAPT regimen. Although the current European Society of Cardiology guidelines provide a backup to individualised treatment, it appears to be difficult to identify the ideal patient profile which could safely reduce or prolong the DAPT duration in daily clinical practice. The aim of this consensus document is to review contemporary literature on optimal DAPT duration, and to guide clinicians in tailoring antiplatelet strategies in patients undergoing PCI or presenting with ACS.

Published
2018
Full Text
View/download PDF

19. The intercultural mediation within society and school

Author

Massimiliano Fiorucci, Stefano Allievi, Maurizio Ambrosini, Benedetto Coccia, Ginevra Demaio, Luca Di Sciullo, Massimiliano Fiorucci, Salvatore Geraci, Giovanna Gianturco, Alberto Guariso, Christopher Hein, Andrea Lasagni, Patrizia Laurano, Maria Paola Nanni, Franco Pittau, Francesco Pompeo, Antonio Ricci, Roberta Ricucci, Andrea Stuppini, Benedetto Coccia, Luca Di Sciullo, and Fiorucci, Massimiliano

Published
2020

Catalog

Books, media, physical & digital resources
See catalog results